Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 676–690 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-1943
SDHB Gene (Paraganglioma Type 4) Next‑Generation Sequencing Test

This test evaluates the SDHB gene for pathogenic variants associated with hereditary paraganglioma-pheochromocytoma type 4 syndrome.

Whole blood (EDTA), genomic DNA, or dried blood spot (FTA) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Germline pathogenic variants in the SDHB gene", "Single-nucleotide variants (SNVs)", "Copy-number variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Diagnosis of hereditary paraganglioma-pheochromocytoma type 4 syndrome", "Risk assessment for individuals with a family history of paraganglioma/pheochromocytoma", "Pre-symptomatic testing in at-risk family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 89464-7 ICD-10: C75.5, D44.7, Z15.09
Clinical summary
This test evaluates the SDHB gene for pathogenic variants associated with hereditary paraganglioma-pheochromocytoma type 4 syndrome.
TEST-1945
SDHD Gene (Paraganglioma & GIST) Genetic Test

This genetic test identifies germline mutations in the SDHD gene associated with hereditary paraganglioma-pheochromocytoma syndrome and GIST.

Peripheral whole blood (EDTA), DNA FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SDHD gene mutations", "Germline variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Suspected hereditary paraganglioma-pheochromocytoma syndrome", "Suspected hereditary GIST", "Family history of paraganglioma, pheochromocytoma, or GIST"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 56143-8 ICD-10: C75.5, D44.6
Clinical summary
This genetic test identifies germline mutations in the SDHD gene associated with hereditary paraganglioma-pheochromocytoma syndrome and GIST.
TEST-267
SELEX Sequencing and Analysis Test

This test identifies and characterises high-affinity DNA or RNA aptamers using SELEX and NGS.

Whole Blood (peripheral) or Extracted DNA 8 weeks (end-to-end including validation) 4,500.00 AED
View
View test specifications and preparation
What it measures
["High-affinity DNA or RNA aptamers", "Target affinity metrics", "Aptamer sequence annotation"]
Parameters
[]
Preparation
[]
Indications
["Diagnostic refinement", "Research purposes", "Personalised therapeutic monitoring", "Companion diagnostics"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93367-2 ICD-10: Z01.89
Clinical summary
This test identifies and characterises high-affinity DNA or RNA aptamers using SELEX and NGS.
TEST-164
SELEX Sequencing Data Analysis Test

This test provides a comprehensive bioinformatics analysis of SELEX libraries using NGS to identify high-affinity aptamers.

Whole Blood (peripheral venous) 4 weeks 2,500.00 AED
View
View test specifications and preparation
What it measures
["High-affinity DNA/RNA aptamers", "Oligonucleotide ligands", "Biomarker discovery potential", "Personalized therapy planning insights"]
Parameters
[]
Preparation
[]
Indications
["Biomarker discovery research", "Personalized therapy planning", "Oncology research", "Rheumatology research", "Anti-aging research"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51969-4 ICD-10: Z13.9
Clinical summary
This test provides a comprehensive bioinformatics analysis of SELEX libraries using NGS to identify high-affinity aptamers.
TEST-5996
SERPINA1 Gene (Alpha-1 Antitrypsin Deficiency) Genetic Test

This test identifies pathogenic variants in the SERPINA1 gene associated with Alpha-1 Antitrypsin Deficiency (AATD). It provides a comprehensive genetic assessment for individuals...

Whole Blood / FTA Card / Extracted DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SERPINA1 gene sequence", "Pathogenic variants in coding regions and splice sites"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustment needed"]
Indications
["Symptomatic patients suspected of AATD", "Family screening for AATD carriers", "Pre-conception risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-8 ICD-10: E88.01
Clinical summary
This test identifies pathogenic variants in the SERPINA1 gene associated with Alpha-1 Antitrypsin Deficiency (AATD). It provides a comprehensive genetic assessment for individuals at risk of or affected by AATD.
TEST-4157
SFTPA1 Gene Idiopathic Pulmonary Fibrosis Genetic Test

This genetic test analyzes the SFTPA1 gene for pathogenic variants associated with idiopathic pulmonary fibrosis (IPF) and familial interstitial pneumonia.

Peripheral whole blood (EDTA tube) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SFTPA1 gene variants", "Pathogenic mutations (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["Genetic counselling session required before sample collection", "Inform lab of recent medications or transfusions", "Fasting is not required"]
Indications
["Suspected idiopathic pulmonary fibrosis (IPF)", "Family history of pulmonary fibrosis", "Need for risk stratification in relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81303-0 ICD-10: J84.112
Clinical summary
This genetic test analyzes the SFTPA1 gene for pathogenic variants associated with idiopathic pulmonary fibrosis (IPF) and familial interstitial pneumonia.
TEST-4045
SH3TC2 Gene (CMT4C) Genetic Test

This test analyzes the SH3TC2 gene for pathogenic variants associated with Charcot-Marie-Tooth disease type 4C (CMT4C). It uses next-generation sequencing for comprehensive analysi...

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SH3TC2 gene", "Presence of mutations causing CMT4C"]
Parameters
[]
Preparation
["Detailed medical history required", "Family pedigree required"]
Indications
["Confirmation of suspected CMT4C diagnosis", "Genetic counseling for families with CMT4C", "Personalized management guidance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-0 ICD-10: G60.0
Clinical summary
This test analyzes the SH3TC2 gene for pathogenic variants associated with Charcot-Marie-Tooth disease type 4C (CMT4C). It uses next-generation sequencing for comprehensive analysis.
TEST-3116
Sickle Cell Anemia Trio Prenatal Mutation Detection Test

This test identifies pathogenic variants in the HBB gene using fetal DNA from amniotic fluid and parental blood samples.

Amniotic Fluid (fetal DNA), Maternal Whole Blood, Paternal Whole Blood 4 business days (Sample Mon by 11 am β†’ Report Fri) 1,800.00 AED
View
View test specifications and preparation
What it measures
["HBB gene variants", "Fetal genotype", "Parental alleles"]
Parameters
[]
Preparation
["Must accompany sample: Duly filled Prenatal Genetic Testing Consent Form (Form 18) and Genomics Clinical Information Requisition Form (Form 20).", "Procedure performed under supervision of a qualified obstetrician and genetic counselor."]
Indications
["Prenatal screening for sickle cell anemia", "Family history of sickle cell disease", "Carrier screening results indicating risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21667-7 ICD-10: D57.1, O35.9XX0, Z14.0
Clinical summary
This test identifies pathogenic variants in the HBB gene using fetal DNA from amniotic fluid and parental blood samples.
TEST-1139
Sickle Cell Mutation Screening (Prenatal) Test

This test detects the presence of the specific point mutation in the beta-globin gene responsible for sickle cell disease in fetal DNA.

Amniotic fluid, chorionic villi, or cord blood 3–4 business days 800.00 AED
View
View test specifications and preparation
What it measures
["Presence of HbS mutation in beta-globin gene", "Fetal DNA analysis"]
Parameters
[]
Preparation
[]
Indications
["Prenatal screening for sickle cell disease", "Risk assessment based on parental carrier status", "Prenatal counseling and planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50398-7 ICD-10: D57.1
Clinical summary
This test detects the presence of the specific point mutation in the beta-globin gene responsible for sickle cell disease in fetal DNA.
TEST-3554
SLC26A4 Gene Sequencing for Pendred Syndrome Test

This test identifies mutations in the SLC26A4 gene associated with Pendred syndrome.

Peripheral whole blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SLC26A4 gene mutations", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Diagnosis of Pendred syndrome", "Carrier screening", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48801-0 ICD-10: E07.1
Clinical summary
This test identifies mutations in the SLC26A4 gene associated with Pendred syndrome.
TEST-3896
SLC3A1 Gene Cystinuria DNA Test (NGS)

This test identifies pathogenic variants in the SLC3A1 gene associated with autosomal recessive cystinuria.

Peripheral Whole Blood (EDTA) or Buccal Swab 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC3A1 gene", "Cystine transporter function (indirectly)"]
Parameters
[]
Preparation
[]
Indications
["Recurrent radiolucent kidney stones", "Confirmed family history of cystinuria", "Elevated urinary cystine levels requiring definitive diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101270-2 ICD-10: E72.01
Clinical summary
This test identifies pathogenic variants in the SLC3A1 gene associated with autosomal recessive cystinuria.
TEST-6234
SLC40A1 Gene Hemochromatosis Type 4 Genetic Test

This genetic test evaluates the SLC40A1 gene for mutations associated with hereditary hemochromatosis type 4 (ferroportin disease). It identifies pathogenic variants causing iron o...

Whole blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks (Fast-Track available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the SLC40A1 gene", "Loss-of-function variants", "Gain-of-function variants"]
Parameters
[]
Preparation
["No special dietary or medication adjustments needed", "Mandatory pre-test genetic counseling session required"]
Indications
["Comprehensive hereditary hemochromatosis evaluation", "Cascade testing for family members", "Investigation of unexplained iron overload", "Evaluation of elevated ferritin or chronic liver disease", "First-line screening in patients with compatible symptoms or family history"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21671-6 ICD-10: E83.119
Clinical summary
This genetic test evaluates the SLC40A1 gene for mutations associated with hereditary hemochromatosis type 4 (ferroportin disease). It identifies pathogenic variants causing iron overload.
TEST-6299
SLC6A14 Gene Cystic Fibrosis‑Related Genetic Test

This test evaluates the SLC6A14 gene for pathogenic variants that act as cystic fibrosis modifiers.

Peripheral whole blood or FTA card blood spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC6A14 gene", "Single nucleotide variants", "Small insertions or deletions"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Individuals with cystic fibrosis", "Family members of individuals with cystic fibrosis", "Carrier screening", "Assessment of disease severity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E84.9, Z13.228
Clinical summary
This test evaluates the SLC6A14 gene for pathogenic variants that act as cystic fibrosis modifiers.
TEST-3850
SLC7A9 Gene (Cystinuria) Genetic Test

This genetic test identifies pathogenic variants in the SLC7A9 gene, which are associated with an increased risk of developing cystinuria and recurrent cystine kidney stones.

Whole Blood, Extracted DNA, One-Drop Blood on FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC7A9 gene", "Single-nucleotide variants", "Small insertions or deletions", "Copy number variations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions or transplants"]
Indications
["Suspected hereditary cystinuria", "Recurrent cystine kidney stones", "Family history of cystinuria", "Evaluation of kidney stone risk"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94244-6 ICD-10: E72.0
Clinical summary
This genetic test identifies pathogenic variants in the SLC7A9 gene, which are associated with an increased risk of developing cystinuria and recurrent cystine kidney stones.
TEST-2007
SMARCE1 Gene Familial Meningioma Susceptibility NGS Test

This test evaluates the SMARCE1 gene for pathogenic variants associated with an increased risk of familial meningioma.

Whole Blood, Extracted DNA, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SMARCE1 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number variants"]
Parameters
[]
Preparation
[]
Indications
["Individuals with a family history of meningioma", "Patients diagnosed with multiple meningiomas", "Risk assessment for familial meningioma susceptibility"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95819-4 ICD-10: Z15.09
Clinical summary
This test evaluates the SMARCE1 gene for pathogenic variants associated with an increased risk of familial meningioma.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area